Background: Styrene is an important building-block petrochemical and monomer used to produce numerous plastics. Whereas styrene bioproduction by Escherichia coli was previously reported, the long-term potential of this approach will ultimately rely on the use of hosts with improved industrial phenotypes, such as the yeast Saccharomyces cerevisiae.

Results: Classical metabolic evolution was first applied to isolate a mutant capable of phenylalanine over-production to 357 mg/L. Transcription analysis revealed up-regulation of several phenylalanine biosynthesis pathway genes including ARO3, encoding the bottleneck enzyme DAHP synthase. To catalyze the first pathway step, phenylalanine ammonia lyase encoded by PAL2 from A. thaliana was constitutively expressed from a high copy plasmid. The final pathway step, phenylacrylate decarboxylase, was catalyzed by the native FDC1. Expression of FDC1 was naturally induced by trans-cinnamate, the pathway intermediate and its substrate, at levels sufficient for ensuring flux through the pathway. Deletion of ARO10 to eliminate the competing Ehrlich pathway and expression of a feedback-resistant DAHP synthase encoded by ARO4[subscript K229L] preserved and promoted the endogenous availability precursor phenylalanine, leading to improved pathway flux and styrene production. These systematic improvements allowed styrene titers to ultimately reach 29 mg/L at a glucose yield of 1.44 mg/g, a 60% improvement over the initial strain.

Conclusions: The potential of S. cerevisiae as a host for renewable styrene production has been demonstrated. Significant strain improvements, however, will ultimately be needed to achieve economical production levels.

The R-specific alcohol dehydrogenase (ADH) from Lactobacillus brevis LB19 (LbADH) was studied with respect to its ability to reduce a series of 3- through 5-carbon 2-alkanones and aldehydes of relevance as biofuel precursors. Although active on all substrates tested, LbADH displays a marked preference for longer chain substrates. Interestingly, however, 2-alkanones were found to impose substrate inhibition towards LbADH, whereas aldehyde substrates rendered no such effect. Inhibition caused by 2-alkanones was furthermore found to intensify with increasing chain length. Despite demonstrating both primary and secondary ADH activities, a preliminary sequence analysis suggests that LbADH remains distinct from other, previously characterized primary-secondary ADHs. In addition to further characterizing the substrate range of this industrially important enzyme, this study suggests that LbADH has the potential to serve as a useful enzyme for the engineering of various novel alcohol biofuel pathways.

With the ability to perform a multitude of unique and complex chemical transformations, microorganisms have long been the “workhorses” of many industrial processes. However, in addition to exploiting the utility of naturally evolved phenotypes, the principles, strategies, and tools of synthetic biology are now being applied to facilitate the engineering of tailor-made microbes capable of tackling some of society's most important and toughest challenges. Fueled in part by exponentially increasing reservoirs of bioinformatic data and coupled with more robust and powerful tools for its processing, research in the past decade has brought about new and broadened perspectives of fundamental biological phenomena. The application of said insight is now beginning to unlock the unprecedented potential of synthetic biology in biotechnology, as well as its considerable promise for addressing previously unsolved global challenges. For example, within the realm of industrial microbiology, progress in the field of synthetic biology has enabled the development of new biosynthetic pathways for the production of renewable fuels and chemicals, programmable logic controls to regulate and optimize complex cellular functions, and robust microbes for the destruction of harmful environmental contaminants. In this Research Topic, a collection of articles—including original research, reviews, and mini-reviews—from leading investigators in the synthetic biology community are presented to capture the current state, recent progress, and over-arching challenges associated with integrating synthetic biology with industrial microbiology and biotechnology.